Oral Presentations
Basic and clinical research of cognitive impairment
13:30-15:00 26th October
Chairs
CAO Yunpeng，YE Qinyong，WANG Yu
Presentations
13:30-13:38
Pharmacogenomics as a transformative approach to targeted Alzheimer's Disease treatment: a systematic review
Dr. Michelle Anlacan, Philippine
13:38-13:46
Higher anticholinergic burden in patients with dementia admitted to acute geriatric ward in Singapore
Ho Peiying Audrey, Singapore
13:46-13:54
Retina as a potential biomarker for the early stage of Alzheimer’s disease spectrum
GAO Rong, Tongji Hospital, Tongji Medical College of HUST
13:54-14:02
Screening of diagnostic circulating biomarkers and exploration of immune cell infiltration in post-stroke dementia
XIAO Yan, Xinjiang Production and Construction Corps
14:02-14:10
N-terminal-targeted anti-amyloid monoclonal antibodies illuminate the therapy for Alzheimer's disease
ZHENG Jiayi, Guangzhou University of Chinese Medicine
14:10-14:18
Z-Guggulsterone attenuates cognitive defects and decreases neuroinflammation in APPswe/PS1dE9 mice through inhibiting the TLR4 signaling pathway
WEI Chao, 301 Military Hospital, China
14:18-14:26
Regulatory Mechanism of PPXY Motifs in the Degradation of Patched 1, a Transmembrane Receptor in the Sonic Hedgehog Signaling Pathway
Chuang Yao-chen, Macau SAR, China
14:26-14:34
Chronic ghrelin administration suppresses IKK/NF-κB/BACE1 mediated Aβ production in primary neurons and improves cognitive function via upregulation of PP1 in STZ-diabetic rats
MA Louyan, Xi’an No.9 Hospital
14:34-14:42
The Role and Mechanism of MMP-9/β-DG Regulating AQP4 Tetrandrine regulates neuron autophage by targeting the mTOR signal pathway in experimental traumatic brain injury
WANG Yanzhe, China Medical University
14:42-14:50
The Role and Mechanism of MMP-9/β-DG Regulating AQP4 Internalization-Degradation Involved In Diabetes Associated Cognitive Dysfunction
YUAN Ye, Xi’an Jiaotong University
14:50-15:00
Discussion